Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Chedid

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Critical Reviews in Immunology|January 1, 1988
Future prospects for vaccine adjuvantsH S Warren, L A Chedid
Reviews of Infectious Diseases|September 1, 1987
Strategies for the treatment of endotoxemia: significance of the acute-phase responseH S Warren, L A Chedid
Infection and Immunity|June 1, 1986
Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell cultureF Dubor, A M Dosne, L A Chedid
Cellular Immunology|July 1, 1987
Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptidesG M Bahr, L A Chedid, K Behbehani
Infection and Immunity|June 1, 1980
Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected miceM A Parant, F J Parant, L A Chedid
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 1, 1996
Enhancement in vivo of the antiinflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutideG M Bahr, P R Pouillart, L A Chedid
Infection and Immunity|August 1, 1985
Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodiesG M Bahr, D S Tello, L A Chedid
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1996
Synergistic effects between recombinant interleukin-2 and the synthetic immunomodulator murabutide: selective enhancement of cytokine release and potentiation of antitumor activityG M Bahr, E Darcissac, P R Pouillart, et al.
Cellular Immunology|April 15, 1991
Influence of a muramyl dipeptide on human blood leukocyte functions and their membrane antigensG J Riveau, B G Brunel-Riveau, F M Audibert, et al.
Infection and Immunity|January 1, 1988
Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factorH S Warren, G R Riveau, F A de Deckker, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Critical Reviews in Immunology|January 1, 1988
Future prospects for vaccine adjuvantsH S Warren, L A Chedid
Reviews of Infectious Diseases|September 1, 1987
Strategies for the treatment of endotoxemia: significance of the acute-phase responseH S Warren, L A Chedid
Infection and Immunity|June 1, 1986
Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell cultureF Dubor, A M Dosne, L A Chedid
Cellular Immunology|July 1, 1987
Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptidesG M Bahr, L A Chedid, K Behbehani
Infection and Immunity|June 1, 1980
Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected miceM A Parant, F J Parant, L A Chedid
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 1, 1996
Enhancement in vivo of the antiinflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutideG M Bahr, P R Pouillart, L A Chedid
Infection and Immunity|August 1, 1985
Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodiesG M Bahr, D S Tello, L A Chedid
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1996
Synergistic effects between recombinant interleukin-2 and the synthetic immunomodulator murabutide: selective enhancement of cytokine release and potentiation of antitumor activityG M Bahr, E Darcissac, P R Pouillart, et al.
Cellular Immunology|April 15, 1991
Influence of a muramyl dipeptide on human blood leukocyte functions and their membrane antigensG J Riveau, B G Brunel-Riveau, F M Audibert, et al.
Infection and Immunity|January 1, 1988
Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factorH S Warren, G R Riveau, F A de Deckker, et al.
Pageof 3